Grifols (GIKLY) Income from Non-Controlling Interests (2010 - 2023)

Grifols (GIKLY) posted Income from Non-Controlling Interests of $130569.6 for Q4 2023, up 103.57% quarter-over-quarter from $64139.9 in Q4 2022, and up 103.57% year-on-year from $64139.9 in Q4 2022.

Grifols (GIKLY) Income from Non-Controlling Interests (2010 - 2023) Analysis & Trends

Grifols (GIKLY) has reported Income from Non-Controlling Interests for 12 consecutive years, with $130569.6 the latest figure, recorded in Q4 2023.

  • Income from Non-Controlling Interests for Q4 2023 came in at $130569.6, up 103.57% year-over-year; the trailing twelve-month figure through Dec 2023 was -$18.6 million (down 11.57% YoY), and the FY2025 annual result was $114.1 million, up 90.63% from the prior year.
  • Income from Non-Controlling Interests was $130569.6 for Q4 2023 at Grifols, up from $64139.9 in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $130569.6 in Q4 2023 and troughed at -$18.9 million in Q1 2020.
  • Average Income from Non-Controlling Interests over 4 years is -$4.7 million, with a median of $82649.9 recorded in 2019.
  • Year-over-year, Income from Non-Controlling Interests surged 115.33% in 2019 and tumbled 18826.37% in 2020.
  • Over 4 years, Income from Non-Controlling Interests stood at $101160.0 in 2019, then sank by 18826.37% to -$18.9 million in 2020, then jumped by 100.34% to $64139.9 in 2022, then jumped by 103.57% to $130569.6 in 2023.
  • Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were $130569.6 in Q4 2023, $64139.9 in Q4 2022, and -$18.9 million in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 2.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 1.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -3.00 Mn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 8.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Grifols - - - -

Historic Data

Download Data
DateValue
Dec 31, 2023 130,569.61
Dec 31, 2022 64,139.89
Mar 31, 2020 -18.94 Mn
Mar 31, 2019 101,159.97
Dec 31, 2018 2.06 Mn
Jun 30, 2018 668,328.87
Mar 31, 2018 -659,722.11
Dec 31, 2017 -1.22 Mn
Jun 30, 2017 256,194.99
Mar 31, 2017 -274,874.98
Dec 31, 2016 -353,069.82
Sep 30, 2016 256,722.43
Jun 30, 2016 76,831.50
Dec 31, 2015 -1.98 Mn
Sep 30, 2015 201,323.57
Jun 30, 2015 -278,495.60
Mar 31, 2015 -754,728.11
Dec 31, 2014 833,638.93
Sep 30, 2014 848,139.23
Jun 30, 2014 721,604.52